Remove Bone Scan Remove Disease Remove Imaging
article thumbnail

Bone scans may be viable for diagnosing calciphylaxis

AuntMinnie

Technetium-99m (Tc-99m) methyl diphosphonate (MDP) bone scans are a potentially viable noninvasive option for diagnosing calciphylaxis, according to a team at the University of Massachusetts in Worcester, MA. The team assessed the potential diagnostic utility of bone scans in calciphylaxis based on a review of the literature.

Bone Scan 297
article thumbnail

Italian research team shows the way on sustainability

AuntMinnie

The new horizons of advanced imaging, especially in oncology, must increasingly consider not only diagnostic efficacy but also sustainability for patients, prize-winning researchers told ECR 2025 delegates. Whole-body MRI is emerging as a superior tool for assessing bone marrow and monitoring therapy response in advanced breast cancer.

Bone Scan 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PSMA-PET provides long-term benefits

AuntMinnie

Prostate-specific membrane antigen (PSMA) PET imaging could improve the length and quality of life for patients with recurrent prostate cancer, according to a study published October 23 in JAMA Network Open. population and was informed by data from real-world settings.

article thumbnail

SPECT/CT improves management of Pluvicto patients

AuntMinnie

SPECT/CT imaging can help manage patients undergoing radiopharmaceutical therapy (RPT) with Pluvicto for advanced prostate cancer, according to a study published August 8 in the Journal of Nuclear Medicine. Yet whether SPECT/CT can be used to determine disease progression or response has yet to be delineated, they noted.

article thumbnail

PET tracer shows promise in prostate cancer patients

AuntMinnie

Moreover, the approach could help detect disease that other effective prostate cancer PET radiotracers may miss, said Heying Duan, MD, a nuclear medicine research scientist at Stanford University, during a November 26 scientific session. Image courtesy of Heying Duan, MD, Stanford University.

article thumbnail

PSMA-PET superior to MRI in phase II prostate cancer trial

AuntMinnie

PET/CT imaging with a new radiotracer (F-18 PSMA-1007) is superior to MRI prior to surgery in men with intermediate-risk and high-risk prostate cancer, according to a study published on July 1 in JAMA Oncology. Out of 150 men who participated, 134 ultimately underwent radical prostatectomies (the mean age was 62 years old).

MRI 264
article thumbnail

The rise of theranostics: Part 4 -- Women's theranostics on the horizon

AuntMinnie

Theranostics is increasingly being used to image and treat prostate cancer and neuroendocrine tumors. Several presenters at the Society for Nuclear Medicine and Molecular Imaging's (SNMMI) 2024 meeting in Toronto shared new findings in women's studies. Women's theranostics appears to already be on the horizon.

Disease 264